Uterine Artery Embolization and Pelvic Floor Symptoms
Status: | Withdrawn |
---|---|
Conditions: | Cancer, Urology |
Therapuetic Areas: | Nephrology / Urology, Oncology |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 5/24/2018 |
Start Date: | January 1, 2009 |
End Date: | January 1, 2013 |
Effect of Uterine Artery Embolization on Symptoms of Pelvic Floor Dysfunction
The objective of this study is to determine whether women who are already receiving treatment
for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual
dysfunction as well.
for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual
dysfunction as well.
Inclusion Criteria:
- female
- age 18-80 years
- symptomatic uterine fibroids
- scheduled for UAE
- Negative urine dipstick (negative result = trace or less for leukocytes & nitrites) or
negative UA or negative culture (Urine dipstick is performed as standard of care)
- Available for 12-months of follow-up and able to complete study assessments, per
clinician judgment
- Signed consent form
Exclusion Criteria:
- Age <18 or >80 years
- women who are unable to read and write English,
- pregnancy or planned pregnancy in the next 12 months
- < 6 months postpartum
- current use of anticholinergic medication, cholinergic agonists, tricyclic
antidepressants, or duloxetine - must have been off such drugs for at least 4 weeks
- women with surgery for urinary incontinence or pelvic organ prolapse in the past 6
months
- history of bladder or pelvic cancer or pelvic radiation therapy
- prior augmentation cystoplasty
- urethral diverticulum, current or repaired.
We found this trial at
1
site
University of Texas Southwestern Medical Center UT Southwestern is an academic medical center, world-renowned for...
Click here to add this to my saved trials